Dr. Patrick John Larrazabal, MD

Dr. Larrazabal practices at Afermin Primary Care PA in South Daytona, Florida.

Dr. Larrazabal's NPI, 1518923275, was assigned on April 21, 2006. Dr. Larrazabal graduated from Cebu Institute of Medicine in 1989. Dr. Larrazabal holds Florida license ME0086562.

Dr. Larrazabal's primary practice is Afermin Primary Care PA, at 2089 S Ridgewood Ave, South Daytona, FL 32119 in Volusia County. The practice phone is (386) 767-7533.

Dr. Larrazabal's primary practice is Afermin Primary Care PA in South Daytona, Florida. Dr. Larrazabal is also affiliated with AdventHealth Daytona Beach. The medical group on file is Afermin Primary Care PA. Dmand AI also links Dr. Larrazabal to 3 more hospitals, 3 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Larrazabal practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Larrazabal's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Larrazabal is board certified in internal medicine by the National Board of Physicians and Surgeons. Dmand AI has Dr. Larrazabal's licenses on file in 2 states: Florida and Alabama.

Dmand AI lists acid reflux, acute gastroduodenitis, acute sinusitis, acute skin infection, adjustment disease, alzheimer's disease, aneurysm and aortic atherosclerois among the conditions Dr. Larrazabal treats.

CMS data shows 1,969 Medicare services from Dr. Larrazabal across 16 procedure codes in 2024, for 312 Medicare patients. Medicare paid $145,204 for them. Every service was in an office.

CMS counts 312 Medicare patients who saw Dr. Larrazabal in 2024. The largest group is 65 to 74, with 124 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Larrazabal's median patient age at 67, with 50% women.

In 2024, Dr. Larrazabal wrote 11,810 Medicare Part D claims for 756 patients. 85% of them were for generic drugs. CMS names the drug for 11,009 of them, across 149 drugs with 11 or more claims each, at $1,452,846 in total drug cost. In 2023, CMS named 9,884 claims across 144 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Larrazabal for performance year 2024, reported individually. Dr. Larrazabal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 155 general payments to Dr. Larrazabal from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Novo Nordisk Inc paid the most, $454.

Dr. Larrazabal graduated from Cebu Institute of Medicine in 1989.

Dr. Larrazabal is in network with 13 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.